Lv32
260 积分 2024-07-11 加入
Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial
1个月前
已完结
Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma: an individual patient data meta-analysis
1个月前
已完结
Novel time-synchronized immune-guided partial tumor irradiation: Proof of principle trial
1个月前
已完结
Middle Meningeal Origin of the Ophthalmic Artery
2个月前
已完结
Radiotherapy Alone vs. Concurrent or Adjuvant Chemoradiotherapy for Nasopharyngeal Carcinoma Patients with Negative Epstein-Barr Virus DNA Post-Induction Chemotherapy
2个月前
已完结
Sintilimab, stereotactic body radiotherapy and granulocyte-macrophage colony stimulating factor as second-line therapy for advanced non-small cell lung cancer: safety run-in results of a multicenter, single-arm, phase II trial
2个月前
已完结
Sintilimab in combination with stereotactic body radiotherapy and granulocyte-macrophage colony-stimulating factor in metastatic non-small cell lung cancer: The multicenter SWORD phase 2 trial
2个月前
已完结
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
2个月前
已完结
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
2个月前
已完结
Prolonged interval hypofractionated radiotherapy facilitates better antitumor immunity
2个月前
已完结
皖公网安备34019202002308
